Income Statement

HAEMONETICS CORP

HAE
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Mar 31, 2025 2024 FY Mar 31, 2024 2023 FY Mar 31, 2023 2022 FY Mar 31, 2022 2021 FY Mar 31, 2021 2020 FY Mar 31, 2020 2019 FY Mar 31, 2019 2018 FY Mar 31, 2018 2017 FY Mar 31, 2017 2016 FY Mar 31, 2016 2015 FY Mar 31, 2015 2014 FY Mar 31, 2014 2013 FY Mar 31, 2013 2012 FY Mar 31, 2012 2011 FY Mar 31, 2011 2010 FY
Revenue
- - - - - - - - - - - - - - -
Cost of Revenue
611.87 617.51 553.56 487.69 472.63 503.97 550.04 - - - - - - - -
Gross Profit
748.96 691.55 615.10 505.50 397.84 484.51 417.54 411.91 378.49 405.91 434.42 468.37 428.13 369.24 355.21
Operating Expenses
527.14 526.67 459.06 424.75 308.09 381.16 333.99 355.75 397.88 449.86 393.88 421.04 371.69 280.48 244.66
Research & Development
62.72 54.44 50.13 46.80 32.86 30.88 35.71 39.23 37.56 44.97 54.19 54.20 44.39 36.80 32.66
Selling, General & Administrative
436.79 431.78 376.68 339.56 274.19 299.68 298.28 316.52 301.73 317.22 334.25 365.13 323.05 245.26 213.90
Other Operating Expenses
- - - - - - - - - - - - - - -
Operating Income
221.82 164.88 156.03 80.75 89.75 103.35 83.55 56.16 -19.38 -43.94 40.54 47.33 56.44 88.76 110.55
Non-Operating Income
9.75 13.02 14.63 17.12 16.83 16.20 9.91 -3.48 8.10 9.47 9.38 10.93 6.54 -0.74 0.47
Interest Income
- - - - - - - - - - - - - - 0.38
Interest Expense
35.90 19.50 13.00 5.80 9.40 13.50 - - - - - - - - 0.01
Other Non-Op Income / Expense
-9.75 -13.02 -14.63 -17.12 -16.83 -16.20 -9.91 -4.53 0.45 8.65 6.74 8.96 -6.54 0.74 -0.85
Income Before Tax
212.07 151.87 141.40 63.63 72.91 87.15 73.63 59.63 -27.48 -53.42 31.17 36.40 49.90 89.50 110.08
Income Tax Expense
44.39 34.31 26.00 20.25 -6.56 10.63 18.61 14.06 -1.21 2.16 14.27 1.25 11.10 22.61 30.10
Non-Controlling Interest
- - - - - - - - - - - - - - -
Net Income
167.68 117.56 115.40 43.38 79.47 76.53 55.02 45.57 -26.27 -55.58 16.90 35.15 38.80 66.89 79.98
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Mar 31, 2025 2024 FY Mar 31, 2024 2023 FY Mar 31, 2023 2022 FY Mar 31, 2022 2021 FY Mar 31, 2021 2020 FY Mar 31, 2020 2019 FY Mar 31, 2019 2018 FY Mar 31, 2018 2017 FY Mar 31, 2017 2016 FY Mar 31, 2016 2015 FY Mar 31, 2015 2014 FY Mar 31, 2014 2013 FY Mar 31, 2013 2012 FY Mar 31, 2012 2011 FY Mar 31, 2011 2010 FY
Depreciation & Amortization
- - - - - - - - - - - - - - -
EBITDA
337.40 262.10 249.34 178.50 174.03 213.64 192.96 145.40 70.35 45.97 126.59 129.07 121.92 138.72 158.69
Earnings Per Share (Basic)
3.33 2.32 2.27 0.85 1.57 1.51 1.07 0.86 -0.51 -1.09 0.33 0.68 0.76 2.64 3.19
Diluted EPS
3.31 2.29 2.24 0.84 1.55 1.48 1.04 0.85 -0.51 -1.09 0.32 0.67 0.74 2.59 3.12
Weighted Average Shares
50.33 50.71 50.78 51.05 50.69 50.69 51.53 52.76 51.52 50.91 51.53 51.61 51.35 25.36 25.08
Diluted Weighted Avg Shares
50.73 51.40 51.42 51.35 51.29 51.82 52.94 53.50 51.52 50.91 52.09 52.38 52.26 25.80 25.60
Comprehensive Income
148.23 112.31 110.97 46.97 95.06 61.77 43.63 59.45 -24.10 -68.90 -6.24 31.13 35.12 66.46 83.62